Clinical Trial Update: Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Xeloda (capecitabine) or tegafur-uracil with folinic acid in advanced or metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Folinic acid (folinic acid)
• UFT (tegafur-uracil)
• Xeloda (capecitabine)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED